Trial Profile
Safety of ChimeriVax Dengue Tetravalent Vaccine in Adult Subjects Previously Immunised With an Investigational Dengue or Yellow Fever Vaccine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2008
Price :
$35
*
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Pharmacodynamics
- 02 Sep 2008 New trial record.